Himachal orders drug recall after 47 samples fail quality tests

5 months ago 1
ARTICLE AD BOX
Image utilized  for representational purposes only.

Image utilized for representational purposes only. | Photo Credit: Getty Images/istockphoto

Notices person been issued to companies whose medicine samples failed prime tests, and they person been instructed to callback their banal from the market, according to Himachal Pradesh State Drug Controller Manish Kapoor.

“Out of 200 medicine samples tested nationwide, 47 were manufactured successful the State. These see medications for fever, bosom attacks, and diabetes. The failed samples originated from assorted districts: 28 from Solan, 18 from Sirmaur, and 1 from Una. Notices person been issued to the respective companies,” officials said connected Saturday (December 20, 2025).

In November 2025, the Central Drugs Standard Control Organisation (CDSCO) collected 65 samples, portion the State Drug Controller collected 135 samples. Of these, 47 samples were identified arsenic substandard. "Notices person been issued to the companies whose medicine samples failed the prime tests. They person besides been asked to callback the banal from the market," Mr. Kapoor said.

“Explanations person been sought, and actions volition beryllium taken against the companies successful accordance with regulations,” Mr. Kapoor informed media unit successful Solan.

The samples of medicines which failed the prime tests see Paracetamol for fever, Clopidogrel and Aspirin for bosom attacks, Metformin for lowering humor sugar, Ramipril for bosom conditions, Sodium Valproate for epilepsy, and Mebeverine Hydrochloride for reducing musculus spasms, on with respective different medicines deemed substandard.

There has been a accordant inclination of medicine samples manufactured successful the State failing prime tests. Health Minister Dhani Ram Shandil had earlier announced that companies with recurring failures would beryllium blacklisted, and that the authorities has been taking enactment successful that regard.

Additionally, a monthly alert issued by the cardinal cause regulator successful March 2025 noted that 38 cause samples produced by assorted pharmaceutical companies successful the State did not conscionable prime parameters.

Published - December 20, 2025 06:44 p.m. IST

Read Entire Article